EUVIMEDEUVIMED entdecken
Fallbericht

Boerhaave syndrome

Tobias Hauge, Aram Abu Hejleh, Magnus Nilsson iD, Wolfgang Schröder iD

British Journal of Surgery · 2024

DOI: 10.1093/bjs/znae216 ↗

Kurz gefasst

Fallbericht in der Zeitschrift British Journal of Surgery, 2024. Verfasst von Tobias Hauge und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric and Gastrointestinal Surgery, Oslo University Hospital, Ullevål, Oslo, Norway. Hauptthemen laut MEDLINE: Esophageal Perforation, Mediastinal Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Boerhaave syndrome is a surgical emergency, defined as a spontaneous perforation of the oesophagus, typically located in the distal left posterolateral aspect The most common clinical presentation is vomitting followed by chest pain combined with signs of infection The initial diagnostic work-up consists of contrast-enhanced CT of the chest and upper abdomen The mainstay of treatment is endoscopic or surgical closure of the oesophageal defect and drainage of perioesophageal fluid collections The choice of initial endoscopic or surgical treatment is largely dependent on the treating centre’s individual experience and preference, with no guidelines currently available Boerhaave syndrome is a surgical emergency defined as a spontaneous perforation of the oesophagus, without external instrumentation and without any other known oesophageal disease. It was first described by the Dutch physician Herman Boerhaave (1668–1738) in 1724, and is thought to result from the mechanical trauma of a sudden increase in intraoesophageal pressure combined with negative intrathoracic pressure, usually in association with severe vomiting or retching1,2. Oesophageal perforation is a rare disease, with an age-standardized incidence rate of 3.1 per 1 000 000 per year, and mortality rates as high as 50% have been reported3. After iatrogenic perforations, Boerhaave syndrome is the second most common cause of all oesophageal perforations, being responsible for approximately 15% of all cases4 (Table 1). Aetiology of oesophageal perforations Balloon dilatation Mucosal resection Submucosal dissection Peroral endoscopic myotomy Sclerotherapy Local endoluminal irradiation Bougienage Laparoscopic fundoplication Laparoscopic myotomy Tumour resection Balloon dilatation Mucosal resection Submucosal dissection Peroral endoscopic myotomy Sclerotherapy Local endoluminal irradiation Bougienage Laparoscopic fundoplication Laparoscopic myotomy Tumour resection Aetiology of oesophageal perforations Balloon dilatation Mucosal resection Submucosal dissection Peroral endoscopic myotomy Sclerotherapy Local endoluminal irradiation Bougienage Laparoscopic fundoplication Laparoscopic myotomy Tumour resection Balloon dilatation Mucosal resection Submucosal dissection Peroral endoscopic myotomy Sclerotherapy Local endoluminal irradiation Bougienage Laparoscopic fundoplication Laparoscopic myotomy Tumour resection The classical Mackler triad, consisting of vomiting, chest pain, and subcutaneous emphysema, is uncommon; more frequently patients present with vague symptoms, making the diagnosis difficult and delaying initiation of specific diagnostic procedures and subsequent treatment. Around 25–45% of patients do not have a history of vomiting and many are initially evaluated for more common medical conditions, that is pneumonia, myocardial infarction or gastro-oesophageal reflux disease5. Approximately 90% of all spontaneous perforations are located in the distal part of the oesophagus, with the majority in the left posterolateral aspect of the intrathoracic oesophagus, possibly owing to an anatomical weakness at this point6. Leakage of gastric content gives rise to mediastinitis (contained perforation) or left pleural effusion (non-contained perforation);, clinically, chest pain and signs of infection ensue. Patients in whom the perforation is in the abdominal part of the oesophagus can present with peritonitis, and the clinical picture may mimic that of a patient with a perforated ulcer. On suspicion of Boerhaave syndrome, the initial diagnostic work-up consists of contrast-enhanced CT of the chest and upper abdomen. Mandatory diagnostic upper endoscopy has historically been controversial as this has been suggested to potentially worsen the perforation2. Endoscopy has, however, become a mandatory part of the diagnostic evaluation at many centres, and should be performed in all patients in whom non-operative management is considered2. As the first diagnostic modality, CT should be carried out, preferably with intravenous and peroral contrast. Radiologically, signs of perforation include pneumomediastinum, oedema of the oesophageal wall, hydropneumothorax (typically left-sided), and oral contrast extravasation7 (Fig. 1). The endoscopic appearance of a perforation is typically a distal, left-sided deep tear or defect (Fig. 2). However, sometimes it may be difficult endoscopically to differentiate a deep oesophageal tear from a full-thickness defect. CT image of a patient with Boerhaave syndrome Image shows pneumomediastinum and leakage of peroral contrast to the left pleural cavity. Upper gastrointestinal endoscopy Image from the same patient as in Fig. 1, taken 4 days after the start of symptoms, showing a defect in the distal oesophagus at 11 o’clock, leading to b mediastinal abscess. The main treatment strategy is to close the defect and drain any perioesophageal fluid collections, including the pleural cavities (Fig. 3). Depending on the patient’s medical condition, time of diagnosis, and local practice, this may be done using either a primarily endoscopic or a primarily surgical approach. Currently, neither a clear evidence base nor guidelines exist, and several treatment modalities and combinations of modalities are used. Flow chart of management principles of Boerhaave syndrome GI, gastrointestinal; MOF, multiple organ failure. Regardless of the main treatment strategy, all patients are held nil per mouth, given intravenous broad-spectrum antibiotics and proton-pump inhibitor as well as nutritional support, typically parenteral. The majority of patients require ICU treatment including various types of organ support. Endoscopic interventional management predominantly comprises endoscopic vacuum treatment (EVT) and oesophageal stenting. In EVT, a sponge of approximately 5–7 cm is connected to a nasogastric tube and a vacuum pump that delivers continuous negative pressure (Fig. 4). The sponge is placed under endoscopic or radiological guidance at the level of the perforation in the tubular oesophagus (intraluminal), or through the perforation into the mediastinum or even the pleural cavity (extraluminal). The optimal interval between each sponge change is yet to be decided, but typically every 3–7 days and more frequently when placed extraluminally8,9. Endoscopic vacuum treatment A 5–7-cm long sponge is connected to a nasogastric tube and a vacuum pump that delivers a continuous negative pressure. Reprinted with permission19. Copyright 2024 E. Johnson, Oslo University Hospital. Stents could be either metal or plastic, fully covered or partially covered, and are typically left in place for 4–6 weeks10. They are all equally efficient in sealing the perforation, but plastic and fully covered metal stents migrate more frequently, whereas partially covered stents could be more difficult to remove because of tissue ingrowth or overgrowth10. In the event of more extensive perforation, the two modalities can successfully be combined. Initially, using EVTs negative vacuum pressure and frequently sponge changes, the defect is ‘cleaned’ allowing stent placement and (if successful closure), the patient to drink. New, and more experimental treatment options include use of combined EVT and stent (VacStent GITM (VAC Stent GmbH, Fulda, Germany)), endoscopic suturing, clips (OTSC® (Ovesco, Tuebingen, Germany), through-the-scope clips), glue, and mesh9,11. Additionally, perioesophageal fluid collections must be drained, mainly by percutaneously CT-guided tubes. Depending on the patient’s clinical condition, a step-up approach may be needed, with additional drains and upscaling of previously placed drains. In patients with empyema, further treatment with fibrinolytics and/or thoracoscopic debridement may be required. Surgery for Boerhaave syndrome differentiates between two main treatment options: primary closure of the oesophageal defect with or without a reinforcement patch, or resection of the oesophageal tube. Depending on the exact location of the perforation, as well as the patient’s body habitus and the surgeon’s preference, access is either through a laparotomy/laparoscopy or a left-sided thoracotomy/thoracoscopy12. In the authors’ experience, most cases can be handled using a laparotomy/laparoscopy for exposure of the gastro-oesophageal junction and distal oesophagus. This approach also offers adequate access to the affected left or, less often, right pleural space. Intraoperative endoscopy may help to clearly visualize the extent of the longitudinal defect as mucosal and muscular layers can be affected differently. For primary closure, the oesophageal defect is closed directly; usually mucosa and the remaining muscle are closed in two different layers using absorbable sutures12. As the mucosal tear is often longer than the muscular tear, a longitudinal myotomy should be performed to expose both mucosal edges. Additional reinforcement may be applied, often using the mobilized gastric fundus. Depending on the location of the defect, other reinforcing patches can be used, including an intercostal or diaphragmatic patch, a pericardial fat or a pleural flap as a buttress12. For larger defects, with extensive surrounding mediastinal inflammation, resection of the tubular oesophagus is required. Depending on the patient’s clinical condition and the degree of contamination, primary reconstruction, often using the gastric tube, can be undertaken at the initial operation. However, as many patients are in poor general condition, the vast majority will not be suited for a primary reconstruction, but must have the oesophagus divided below the level of the gastro-oesophageal junction with placement of a functional cervical oesophagectomy and a gastrostomy for nutritional support12. Secondary, definitive reconstruction can be performed after an interval of at least 6 months with a gastric or colonic interposition, predominantly using the retrosternal route12. At present, no guidelines exist regarding the optimal treatment strategy, and the choice of treatment modality depends primarily on the centre’s individual experience and preference. Over the past decade, endoscopic treatment has increasingly been used, with EVT as the initially and preferred method13. However, many specialized centres opt for surgical intervention in the presence of sepsis with progressive single or multiple organ failure, abdominal perforations, and failed endoscopic treatment14. The type of surgical intervention—primary closure of the defect or oesophageal resection—depends on the intraoperative findings, particularly the extent of mediastinal/pleural inflammation and the patient’s general condition. Outcomes after spontaneous oesophageal perforations are to some degree a scientific unknown, as the majority of previous publications described the outcome after oesophageal perforation in general and not specifically that of patients with Boerhaave syndrome. In patients with benign oesophageal perforation, a delay in diagnosis (over 24 h) is associated with impaired clinical outcome, including increased mortality rates, more ICU readmissions, reinterventions, and longer hospital stay15. Increasing age, co-morbidity, and treatment at low-volume centres (8 cases or fewer per year) are associated with increased treatment failure and 90-day mortality16. Surgery, compared with endoscopic treatment or drainage alone, was associated with decreased mortality in the same study. However, this is highly uncertain, as data were collected retrospectively and analysed according to treatment modality, not type of defect, and significant selection bias is likely. The importance of centralization has been further highlighted in a retrospective nationwide study17 from England, in which treatment at high-volume centres was associated with decreased 30- and 90-day mortality rates. For the correctly selected patient, both surgical and endoscopic treatment is effective in sealing the perforations in 80–100% of all procedures, with resumption of oral diet after a median of 8–11 days and a hospital stay of 17–24 days18–20. Initial treatment with stenting failed in only 2% of patients necessitating surgery20. In the long run, stricture formation is fairly common and occurs in 6–18% of all patients18,19. The mortality rate after Boerhaave syndrome is still high and, based on two fairly recent meta-analyses15,21, approximately 13–16%. Boerhaave syndrome is a surgical emergency, defined as spontaneous perforation of the oesophagus, typically located in the distal posterolateral aspect. It is associated with high morbidity and mortality rates, and the primary management modalities include endoscopic closure, using EVT and/or stenting, or surgery with direct closure of the defect, or even, in some patients, resection, usually with a cervical oesophagostomy. There is major heterogeneity in treatment modalities, depending on the patient’s medical condition, intraoperative findings, and local practice. Further research should focus on identifying the optimal treatment strategy for these patients, and potential prognostic and predictive markers for patient outcome. The authors have no funding to declare. The authors declare no conflict of interest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal PerforationMediastinal DiseasesHumansEsophageal DiseasesRupture, SpontaneousTomography, X-Ray ComputedSpontaneous Perforation

Autor:innen und Institutionen

  • Department of Pediatric and Gastrointestinal Surgery, Oslo University Hospital, Ullevål, Oslo, Norway.
  • Department of General, Visceral, Cancer and Transplantation Surgery, University of Cologne, Cologne, Germany.
  • Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Swede…

ORCID-Profile: Magnus Nilsson, Wolfgang Schröder

Zitieren

APA

Hauge, T., Abu Hejleh, A., Nilsson, M., & Schröder, W. (2024). Boerhaave syndrome. British Journal of Surgery. https://doi.org/10.1093/bjs/znae216

Vancouver

Hauge T, Abu Hejleh A, Nilsson M, Schröder W. Boerhaave syndrome. British Journal of Surgery. 2024. doi:10.1093/bjs/znae216

BibTeX
@article{Hauge2024,
  author = {Hauge, Tobias and Abu Hejleh, Aram and Nilsson, Magnus and Schröder, Wolfgang},
  title = {Boerhaave syndrome},
  journal = {British Journal of Surgery},
  year = {2024},
  doi = {10.1093/bjs/znae216}
}
Kostenlos starten →